DK0629203T3 - Desosaminoderivater af makrolider som immunosuppressive midler og antifungale midler - Google Patents

Desosaminoderivater af makrolider som immunosuppressive midler og antifungale midler

Info

Publication number
DK0629203T3
DK0629203T3 DK93903553T DK93903553T DK0629203T3 DK 0629203 T3 DK0629203 T3 DK 0629203T3 DK 93903553 T DK93903553 T DK 93903553T DK 93903553 T DK93903553 T DK 93903553T DK 0629203 T3 DK0629203 T3 DK 0629203T3
Authority
DK
Denmark
Prior art keywords
macrolides
pct
immunosuppressants
antifungal agents
desosamine
Prior art date
Application number
DK93903553T
Other languages
Danish (da)
English (en)
Inventor
R Hauske James
R Schulte Gary
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0629203T3 publication Critical patent/DK0629203T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK93903553T 1992-03-02 1993-01-27 Desosaminoderivater af makrolider som immunosuppressive midler og antifungale midler DK0629203T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435092A 1992-03-02 1992-03-02
PCT/US1993/000426 WO1993018042A1 (fr) 1992-03-02 1993-01-27 Derives de desosamino de macrolides utiles comme immunosuppresseurs et antifongiques

Publications (1)

Publication Number Publication Date
DK0629203T3 true DK0629203T3 (da) 2001-11-12

Family

ID=25292478

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93903553T DK0629203T3 (da) 1992-03-02 1993-01-27 Desosaminoderivater af makrolider som immunosuppressive midler og antifungale midler

Country Status (12)

Country Link
US (2) US5506233A (fr)
EP (1) EP0629203B1 (fr)
JP (1) JPH07500613A (fr)
AT (1) ATE205496T1 (fr)
CA (1) CA2131371A1 (fr)
DE (1) DE69330747T2 (fr)
DK (1) DK0629203T3 (fr)
ES (1) ES2160593T3 (fr)
FI (1) FI944014A (fr)
GR (1) GR3037059T3 (fr)
PT (1) PT629203E (fr)
WO (1) WO1993018042A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2182004C1 (ru) * 2001-02-22 2002-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Лекарственный препарат для парентерального применения
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US7452692B2 (en) * 2002-02-13 2008-11-18 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Method for extracting a macrolide from biomatter
PL374059A1 (en) 2002-02-13 2005-09-19 Teva Gyogyszergyar Reszvenytarsasag Method for extracting a macrolide from biomatter
US7232486B2 (en) * 2003-03-31 2007-06-19 TEVA Gyógyszergyár Zártkörűen Működő Részvénytársaság Crystallization and purification of macrolides
US20060169199A1 (en) * 2003-03-31 2006-08-03 Vilmos Keri Crystallization and purification of macrolides
US7160867B2 (en) 2003-05-16 2007-01-09 Isotechnika, Inc. Rapamycin carbohydrate derivatives
KR20060052874A (ko) * 2003-07-24 2006-05-19 테바 기오기스제르갸르 레스즈베니타르사사그 마크로라이드의 정제 방법
EP2583678A3 (fr) 2004-06-24 2013-11-13 Novartis Vaccines and Diagnostics, Inc. Immunopotentiateurs de petites molécules et dosages pour leur détection
TW200637834A (en) * 2004-12-22 2006-11-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Method of purifying macrolides
CA2588480A1 (fr) * 2005-01-05 2006-08-10 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Tacrolimus amorphe et sa preparation
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
TW200815458A (en) * 2006-03-15 2008-04-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for purifying Tacrolimus
JP2009203162A (ja) * 2006-06-05 2009-09-10 Astellas Pharma Inc マクロライド化合物の新規製造法
EP2063905B1 (fr) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
AU6286690A (en) * 1989-08-18 1991-04-03 Fisons Plc Macrocyclic compounds
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
EP0466365A3 (en) * 1990-07-03 1992-04-15 Merck & Co. Inc. Novel immunosuppressant fermentation products of a microorganism

Also Published As

Publication number Publication date
DE69330747D1 (de) 2001-10-18
US5506233A (en) 1996-04-09
ES2160593T3 (es) 2001-11-16
JPH07500613A (ja) 1995-01-19
PT629203E (pt) 2002-01-30
DE69330747T2 (de) 2002-05-29
CA2131371A1 (fr) 1993-09-16
WO1993018042A1 (fr) 1993-09-16
EP0629203A1 (fr) 1994-12-21
FI944014A0 (fi) 1994-09-01
EP0629203B1 (fr) 2001-09-12
ATE205496T1 (de) 2001-09-15
FI944014A (fi) 1994-09-01
US5563135A (en) 1996-10-08
GR3037059T3 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
DK0629203T3 (da) Desosaminoderivater af makrolider som immunosuppressive midler og antifungale midler
DK0839126T3 (da) Fremgangsmåde til fremstilling af organiske nitrogenforbindelser, specielle organiske nitrogenforbindelser og blandinger af sådanne forbindelser samt deres anvendelse som brændstof- og smøremiddeladditiver
NO961345L (no) O-aryl, O-alkyl-, O-alkenyl- og O-alkynylmakrolider med immunundertrykkende aktivitet
DK0581959T3 (da) Anvendelse af makrolidforbindelser til øjensygdomme
AR003426A1 (es) Derivados de rapamicina y procedimiento para prepararlos, composiciones farmacéuticas formuladas con dichos derivados y equipos(kits) que incluyen dichos derivados para tratar infecciones,estados inflamatorios o tratamientos inmunosupresores.
DK0992510T3 (da) N6-heterocyklisk substituerede adenosinderivater
ITRM920333A1 (it) Complesso di incernieramento per radiotelefoni ripiegabili.
FI922983A (fi) Pyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa
DE69427286D1 (de) 7,42-bis (o-demethyl)rapamycin
NL194926B (nl) Tweevoudige rakethouder.
MX9401406A (es) Agentes receptores de adenosina selectivos para intensificar el conocimiento.
NO20003397L (no) 3 '-epimerie K-252A-derivater
DK0512754T3 (da) Reduktionsprodukter af rapamycin som immunosuppressive, antiinflammatoriske og antifungale midler
ATE179977T1 (de) Herbizide pyridinverbindungen
DE69314947D1 (de) 2-aminozuckermakrolid-derivate
FI962010A0 (fi) Immuunivastetta heikentävinä aineina käytettäviä 6-okso-nukleosideja
DE69310721T2 (de) Zuckerderivate von makroliden
Hammett The Great Commission and Evangelism in the New Testament
IT1247510B (it) Composizioni terapeutiche ad attivita' anti-hiv costituite da 2',3'-didesossiadenosina e sostanze inibitrici della adenosina-deaminasi
ITBO930200V0 (it) Gruppo radiatori.
ITMO920109A0 (it) Gioco di apprendimento del linguaggio musicale, impiegante piccole parti mobili
IT229823Y1 (it) Stanghetta perfezionata per occhiali, particolarmente studiata per l'agganciamento di un orecchino alla stessa.
GR1001394B (el) Παράγωγα 4-[4-[4-(4-υδροξυφαινυλ)-1-πιπεραζινυλ] φαινυλ]-5-με?υλ3Η-1,2,4-τριαζολ-3-όνης.
IT233631Y1 (it) Scrittoio per posizione eretta, con piano di lavoro attrezzato, elevata componibilita' e riservatezza.
ITAR920009A0 (it) Cella di interruzione per m.t. com peculiarita' atte alla diminuizionedell'ingombro.